F. Citterio

Agostino Gemelli University Polyclinic

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

SciProfiles

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Agostino Gemelli University Polyclinic

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Università Cattolica del Sacro Cuore

Research Subjects

Research Interests

F. Citterio has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

Evaldo Favi
General Surgery and Kidney Transplantation Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy
7 shared publications
Gionata Spagnoletti
Division of Hepatobiliopancreatic Surgery, Liver and Kidney Transplantation Bambino Gesù Children's Hospital IRCCS Rome Italy
4 shared publications
J. Romagnoli
Kidney Transplantation, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy
3 shared publications
Jacopo Romagnoli
Renal Transplant Unit, Organ Transplant Ph.D. Program, Policlinico Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
3 shared publications
M. Paola Salerno
Department of Surgical Science, Renal Transplant Unit, Catholic University, Rome, Italy
3 shared publications
A. Gargiulo
Department of Surgical Science, Renal Transplant Unit, Catholic University, Rome, Italy
2 shared publications

Latest Publications

Sort by

Website
Google Scholar
Cited by 10
- 1 October 2017
- Published by Elsevier in Transplantation Proceedings
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience
by E. Favi, R. Santangelo, S. Iesari, M. Morandi, G.E. Marcovecchio, E.M. Trecarichi, M.P. Salerno, M. Ferraresso, F. Citterio, J. Romagnoli
Website
Google Scholar
- 1 October 2017
- Published by Elsevier in Transplantation Proceedings
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience
by E. Favi, R. Santangelo, S. Iesari, M. Morandi, G.E. Marcovecchio, E.M. Trecarichi, M.P. Salerno, M. Ferraresso, F. Citterio, J. Romagnoli
Cited by 10
Website
Google Scholar
Cited by 8
- 1 September 2014
- Published by Elsevier in Transplantation Proceedings
Posttransplant Encapsulating Peritoneal Sclerosis, Long-Term Success With Everolimus and Low-Dose CNI: A Case Report
by J. Romagnoli, J.A. Pedroso, M. Paola Salerno, E. Favi, G. Spagnoletti, F. Citterio
Website
Google Scholar
- 1 September 2014
- Published by Elsevier in Transplantation Proceedings
Posttransplant Encapsulating Peritoneal Sclerosis, Long-Term Success With Everolimus and Low-Dose CNI: A Case Report
by J. Romagnoli, J.A. Pedroso, M. Paola Salerno, E. Favi, G. Spagnoletti, F. Citterio
Cited by 8
Website
Google Scholar
Cited by 1
- 1 July 2014
- Published by Wolters Kluwer Health in Transplantation
3 Years Outcomes in a Randomized Trial Evaluating Everolimus Plus CNI Reduction in Kidney Transplant Recipients.
by M. Salerno, V. Bianchi, E. Favi, G. Spagnoletti, J. Pedroso, A. Toscano, V. Pietroni, J. Romagnoli, F. Citterio
Website
Google Scholar
- 1 July 2014
- Published by Wolters Kluwer Health in Transplantation
3 Years Outcomes in a Randomized Trial Evaluating Everolimus Plus CNI Reduction in Kidney Transplant Recipients.
by M. Salerno, V. Bianchi, E. Favi, G. Spagnoletti, J. Pedroso, A. Toscano, V. Pietroni, J. Romagnoli, F. Citterio
Cited by 1
Website
Google Scholar
- 1 July 2014
- Published by Wolters Kluwer Health in Transplantation
A New Integrated Clinical-Histological Risk Score Index To Predict The 5-Year Kidney Graft Survival, Based On Data Available at The Time of Transplantation.
by J. Pedroso, E. Favi, M. Salerno, G. Spagnoletti, P. Silvestri, V. Pietroni, A. Toscano, V. Bianchi, J. Romagnoli, F. Citterio
Website
Google Scholar
- 1 July 2014
- Published by Wolters Kluwer Health in Transplantation
A New Integrated Clinical-Histological Risk Score Index To Predict The 5-Year Kidney Graft Survival, Based On Data Available at The Time of Transplantation.
by J. Pedroso, E. Favi, M. Salerno, G. Spagnoletti, P. Silvestri, V. Pietroni, A. Toscano, V. Bianchi, J. Romagnoli, F. Citterio
Website
Google Scholar
Cited by 8
- 30 September 2013
- Published by Elsevier in Transplantation Proceedings
The Reduction of Left Ventricular Hypertrophy After Renal Transplantation Is Not Influenced by the Immunosuppressive Regimen
by M.P. Salerno, E. Rossi, E. Favi, J.A. Pedroso, G. Spagnoletti, J. Romagnoli, F. Citterio
Website
Google Scholar
- 30 September 2013
- Published by Elsevier in Transplantation Proceedings
The Reduction of Left Ventricular Hypertrophy After Renal Transplantation Is Not Influenced by the Immunosuppressive Regimen
by M.P. Salerno, E. Rossi, E. Favi, J.A. Pedroso, G. Spagnoletti, J. Romagnoli, F. Citterio
Cited by 8
Website
Google Scholar
Cited by 3
- 1 May 2011
- Published by Elsevier in Transplantation Proceedings
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study
by G. Spagnoletti, E. Favi, A. Gargiulo, M.P. Salerno, F. Citterio
Website
Google Scholar
- 1 May 2011
- Published by Elsevier in Transplantation Proceedings
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study
by G. Spagnoletti, E. Favi, A. Gargiulo, M.P. Salerno, F. Citterio
Cited by 3
Website
Google Scholar
Cited by 5
- 27 May 2010
- Published by Elsevier in Transplantation Proceedings
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study
by E. Favi, G. Spagnoletti, A. Gargiulo, M.P. Salerno, J. Romagnoli, F. Citterio
Website
Google Scholar
- 27 May 2010
- Published by Elsevier in Transplantation Proceedings
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study
by E. Favi, G. Spagnoletti, A. Gargiulo, M.P. Salerno, J. Romagnoli, F. Citterio
Cited by 5